CorMedix (NYSE Amex: CRMD) Announces Appointment of Key Positions

 Email Article  

Tweet  

  

  

 delicious  

  

  

CorMedix (NYSE Amex: CRMD) announced two additions to their management team today. They were:

1. Robert D. Hopkins as head of clinical operations and project management. Dr. Hopkins has over a decade of clinical operations and project management experience, with a Doctorate of Veterinary Medicine and Masters of Science Biology. Most recently, Dr. Hopkins served as associate director, project management at Quintiles Transnational, Inc., where he had the responsibility of managing multiple projects, establishing SOPs, policies and procedures for client’s clinical programs. Dr. Hopkins’ prior experience includes serving as the senior project manager for PRA International, and clinical trial project manager at Pfizer, Inc., and
2. Dilip Wadgaonkar as head of product development and manufacturing.Mr. Wadgaonkar brings to CorMedix over 20 years of formulation and manufacturing experience, with a Ph.D. in Pharmaceutics and a Masters of Science and Pharmacy. Most recently, Mr. Wadgaonkar served as head of research and development at Sun Pharmaceutical Industries Inc., where he was responsible for establishing the research and development manufacturing processes, and supporting the regulatory affairs divisions for all new drug applications. Mr. Wadgaonkar’s prior experience includes serving as the vice president of research and development for Interpharm Inc., where he oversaw research and development activities including formulation development, analytical aspects, Abbreviated New Drug Application compilation and technology transfer, in addition to serving at Barr Laboratories, Hoffman La Roche, and Wyeth.